MARKET

MLTX

MLTX

MoonLake Immunotherapeutics
NASDAQ
18.20
-0.21
-1.14%
Opening 13:34 05/14 EDT
OPEN
18.50
PREV CLOSE
18.41
HIGH
18.67
LOW
17.86
VOLUME
262.63K
TURNOVER
--
52 WEEK HIGH
62.75
52 WEEK LOW
5.95
MARKET CAP
1.34B
P/E (TTM)
-4.7036
1D
5D
1M
3M
1Y
5Y
1D
MoonLake Immunotherap Price Target Raised to $30.00/Share From $25.00 by Needham
Dow Jones · 2d ago
MoonLake Immunotherap Is Maintained at Buy by Needham
Dow Jones · 2d ago
Needham Maintains Buy on MoonLake, Raises Price Target to $30
Benzinga · 2d ago
Needham Sticks to Its Buy Rating for MoonLake Immunotherapeutics (MLTX)
TipRanks · 2d ago
MoonLake Immunotherapeutics: Buy Rating Reiterated on De-Risked Path to 2026 BLA and Robust SLK Data; $30 Price Target Maintained
TipRanks · 2d ago
Analysts Offer Insights on Healthcare Companies: SI-Bone (SIBN) and MoonLake Immunotherapeutics (MLTX)
TipRanks · 2d ago
FDA Aligns With MoonLake On Lead Drug Submission Plans, Stock Soars
Benzinga · 3d ago
Phil Nadeau Reiterates Buy on MoonLake Immunotherapeutics as Sonelokimab Advances Toward 2027 Launch with $3B+ Peak Sales Potential
TipRanks · 3d ago
More
About MLTX
MoonLake Immunotherapeutics, formerly known as Helix Acquisition Corp, is a Switzerland-based company engaged in the healthcare industry. The Firm is a clinical-stage biopharmaceutical company focused on the development of medicines for immunologic diseases, including inflammatory skin and joint diseases. The Company develops tri-specific nanobody Sonelokimab (SLK) which purpose is to target and penetrate difficult-to-reach inflamed tissues. SLK is a molecule with enhanced enrichment in deep skin & joints and binding of targets. SLK inhibits IL-17A and IL-17F inhibition to treat inflammatory diseases, by independently inhibiting the naturally-occurring IL-17 A/A, A/F and F/F dimers that drive inflammation in patients.

Webull offers MoonLake Immunotherapeutics stock information, including NASDAQ: MLTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MLTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MLTX stock methods without spending real money on the virtual paper trading platform.